Relative resistance primary isolates neutralization soluble Replication human immunodeficiency virus type pathogenesis progression acquired immunodeficiency syndrome AIDS soluble form virus receptor potential therapeutic agent good activity laboratory strains vitro quantitative virologic studies date blood patients recombinant soluble efficacy vivo good drug levels serum results neutralizing activity multiple primary isolates infected patients findings primary isolates resistant laboratory strains need therapies preclinical studies experiments patient viral isolates 